KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) Shares Outstanding (Weighted Average): 2009-2024

Historic Shares Outstanding (Weighted Average) for Quest Diagnostics (DGX) over the last 16 years, with Dec 2024 value amounting to $111.6 million.

  • Quest Diagnostics' Shares Outstanding (Weighted Average) rose 0.45% to $111.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $111.8 million, marking a year-over-year increase of 0.45%. This contributed to the annual value of $111.6 million for FY2024, which is 0.82% up from last year.
  • According to the latest figures from FY2024, Quest Diagnostics' Shares Outstanding (Weighted Average) is $111.6 million, which was up 0.82% from $110.7 million recorded in FY2023.
  • In the past 5 years, Quest Diagnostics' Shares Outstanding (Weighted Average) ranged from a high of $133.5 million in FY2020 and a low of $110.7 million during FY2023.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $111.2 million, with a median of $111.3 million in 2022.
  • Per our database at Business Quant, Quest Diagnostics' Shares Outstanding (Weighted Average) declined by 10.49% in 2021 and then climbed by 0.82% in 2024.
  • Quest Diagnostics' Shares Outstanding (Weighted Average) (Yearly) stood at $133.5 million in 2020, then fell by 10.49% to $119.5 million in 2021, then declined by 6.81% to $111.3 million in 2022, then dropped by 0.55% to $110.7 million in 2023, then climbed by 0.82% to $111.6 million in 2024.